| Name | PHD-1-IN-1 |
|---|---|
| Synonyms |
Benzonitrile, 4-[1,2,4]triazolo[1,5-a]pyridin-5-yl
PHD-1-IN-1, 10 mM in DMSO pocket,ion,g367-out,HIF-PH,Hypoxia-inducible factors,site,active,PHD 1 IN 1,orally,Inhibitor,PHD-1,Fe,PHD1IN1,iron,HIF/HIF Prolyl-Hydroxylase,HIFs,inhibit 4-([1,2,4]Triazolo[1,5-a]pyridin-5-yl)benzonitrile |
| Description | PHD-1-IN-1 is an orally active and potent HIF prolylhydroxylase domain-1 (PHD-1) inhibitor with an IC50 of 0.034 μM. PHD-1-IN-1 has a unique monodentate binding interaction with the active site Fe2+ ion and induces the formation of an “Arg367-out” pocket[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.034 μM (PHD-1)[1] |
| In Vivo | PHD-1-IN-1 (compound 17; 3 mg/kg of p.o. or 0.5 mg/kg of i.v.) has a Cmax of 0.8 μM, a AUC of 176 ng•h/mL, Kp,uu of 1.11 and B/P of 0.95[1]. Animal Model: Male C57BL6 mice[1] Dosage: 3 mg/kg (p.o.) or 0.5 mg/kg (i.v.) (Pharmacokinetic Analysis) Administration: PO or IV Result: Had a Cmax of 0.8 μM, a AUC of 176 ng•h/mL, Kp,uu of 1.11 and B/P of 0.95. |
| References |
| Molecular Formula | C13H8N4 |
|---|---|
| Molecular Weight | 220.23 |